Oramed Pharmaceuticals Inc logo

Oramed Pharmaceuticals Inc

NAS:ORMP (USA)  
$ 2.61 +0.1 (+3.98%) 11:08 PM EST
P/E:
At Loss
P/B:
0.69
Market Cap:
$ 105.12M
Enterprise V:
$ -44.36M
Volume:
66.07K
Avg Vol (2M):
167.90K
Also Trade In:
Volume:
66.07K
Market Cap $:
105.12M
PE Ratio:
At Loss
Avg Vol (2M):
167.90K
Enterprise Value $:
-44.36M
PB Ratio:
0.69

Business Description

Description
Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.
Name Current Vs Industry Vs History
Cash-To-Debt 207.46
Equity-to-Asset 0.97
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 10.37
Distress
Grey
Safe
Beneish M-Score -2.64
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 19.07
9-Day RSI 24.6
14-Day RSI 29.81
6-1 Month Momentum % 49.07
12-1 Month Momentum % -50.39

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 141.49
Quick Ratio 141.49
Cash Ratio 140.77

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -31.5
Shareholder Yield % -0.04

Financials (Next Earnings Date:2023-11-10 Est.)

ORMP's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ORMP

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Oramed Pharmaceuticals Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.703
EPS (TTM) ($) -0.51
Beta 1.81
Volatility % 132.16
14-Day RSI 29.81
14-Day ATR ($) 0.152888
20-Day SMA ($) 2.931
12-1 Month Momentum % -50.39
52-Week Range ($) 1.81 - 13.73
Shares Outstanding (Mil) 40.28

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Oramed Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

Oramed Pharmaceuticals Inc Stock Events

Event Date Price($)
No Event Data

Oramed Pharmaceuticals Inc Frequently Asked Questions

What is Oramed Pharmaceuticals Inc(ORMP)'s stock price today?
The current price of ORMP is $2.61. The 52 week high of ORMP is $13.73 and 52 week low is $1.81.
When is next earnings date of Oramed Pharmaceuticals Inc(ORMP)?
The next earnings date of Oramed Pharmaceuticals Inc(ORMP) is 2023-11-10 Est..
Does Oramed Pharmaceuticals Inc(ORMP) pay dividends? If so, how much?
Oramed Pharmaceuticals Inc(ORMP) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1